Webinar: Preclinical Pharmacokinetics (PK) and Pharmacodynamics (PD) Evaluation with Biocytogen
Our webinar “Preclinical Pharmacokinetics (PK) and Pharmacodynamics (PD) Evaluation with Biocytogen" was live on Sep 29, 2022 at 1PM EDT. An understanding of the exposure-response…
Read more
Research Impact: Custom Biocytogen mouse models used to identify critical mediator of inflammation-driven metastases
By John Charpentier, Ph.D. September 7, 2022 While metastases are ultimately responsible for the large majority of cancer deaths, most oncology drugs in development target…
Read more
Biocytogen Lists on the Main Board of HKEX, Aiming to Become the Headstream of New Drugs
Beijing, China, September 1, 2022 -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced the company’s official listing on the Main Board of the…
Read more
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab
Beijing, China and San Diego, CA, August 29, 2022 - Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced…
Read more
Biocytogen Expands Partnership with Merck
Beijing, China and Darmstadt, Germany, August 25, 2022 -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered into a global licensing agreement with Merck for the…
Read more
2022 Popular Mouse Models and Cell Lines
Biocytogen’s advanced genome editing technologies have been leveraged by our own development scientists to create hundreds of animal and cell models used in biomedical research…
Read more
First Half of 2022 Publications Highlight
Our off-the-shelf and custom animal and cell models are advancing cutting-edge biomedical research every day. One measure of this impact is how often they appear…
Read more
Webinar: Preclinical Models to Investigate NK Cell-Targeted Immunotherapies
Our webinar “Preclinical Models to Investigate NK Cell-Targeted Immunotherapies" was live on Aug 31, 2022 at 1PM EDT. In this webinar, we Reviewed the mechanisms…
Read more
18th International SCBA Symposium
Attend the meeting Talk to us The Society of Chinese Bioscientists in America (SCBA) is a non-profit organization founded by a few prominent and enthusiastic bioscientists…
Read more
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs
Beijing, China and Tokyo, Japan, July 21, 2022 – February 1st 2021, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered a strategic collaboration with LiberoThera Co.,…
Read more